07.04.2018 Views

AD 2016 Q1

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

RESEARCH, EDUCATION & MEDICINE<br />

EXPERT OPINIONS<br />

At each of these three stages there are factors that<br />

modify the effects and outcomes of exposure. In the<br />

absence of specific knowledge, the most common<br />

preventive strategy is to reduce supersaturation by<br />

limiting the depth/time exposure and ascent rate for<br />

all divers to avoid substantial bubbling — even though<br />

bubbles put only some divers (those with a right-toleft<br />

shunt [RLS]) at risk. Without bubbles (or with<br />

only a few), there will be no arterialization, even in<br />

divers with RLS, and there will be no DCS in those<br />

susceptible to arterial embolization.<br />

Several approaches to mitigating postdive bubble<br />

occurrence have been studied; these include predive<br />

removal of hypothetical bubble nuclei by wholebody<br />

vibration, attempts to influence oxygen radicals<br />

or nitric oxide suspected of contributing to bubble<br />

generation, stimulation of heat-shock protein<br />

production and various other methods, including<br />

predive chocolate treats. Although some of these<br />

factors may reduce the amount of bubbles, the effects<br />

vary and may be of less importance than the individual<br />

variation in response to decompression.<br />

If every diver had a consistent individual propensity<br />

for VGE production and could be classified as a<br />

“bubbler” or “nonbubbler” across a broad spectrum of<br />

reasonable dive exposures, safe exposure limits could be<br />

tailored individually. We would achieve greater precision<br />

if we could identify those divers who have persistent<br />

or occasional RLS and then customize a dive exposure<br />

for them. At present we already know that a large<br />

patent foramen ovale (PFO) enables arterialization and<br />

Figure 1.<br />

apparently increases the risk of DCS. A test for PFO is<br />

available. We can identify divers with a large PFO and<br />

close it, but this does not solve the problem for all divers<br />

because RLS may occur in lungs regardless of PFO. Risk<br />

of DCS due to pulmonary RLS may be more difficult to<br />

tackle because pulmonary RLS seems to be part of the<br />

normal physiological response to exercise and far more<br />

prevalent in the population than large PFOs.<br />

It is important to note that even if we could prevent<br />

the occurrence of VGE, DCS could still occur. VGE<br />

do not play a role in pain-only DCS. Some cases of<br />

spinal DCS may be caused by bubbles occurring<br />

locally in tissue, without bubbles in venous blood.<br />

Similarly, some cases of inner-ear DCS may be caused<br />

by local bubbles rather than by arterialized gas emboli.<br />

Cutaneous (skin) manifestations of DCS may be caused<br />

by various mechanisms, some involving embolization<br />

of arterialized VGE and others independent of VGE.<br />

As in lung cancer, the definitive cause of DCS is<br />

an external physical factor that, unlike smoking, we<br />

cannot eliminate if we want to dive. But by controlling<br />

the magnitude of exposure, we can minimize the risk<br />

of DCS. There is still a lot of room to improve the<br />

precision of DCS prediction and develop individually<br />

tailored preventive exposure restrictions. This can be<br />

achieved by advancing VGE study methods and dive<br />

population studies to identify individuals who may<br />

easily produce VGE or are prone to arterialization.<br />

Understanding why some divers easily produce VGE<br />

and why some are more prone to DCS in the case of<br />

52 | WINTER <strong>2016</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!